Health Care/Hospital

Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019

WENZHOU, China, Nov. 5, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced that ...

2019-11-06 05:05 5625

Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data and Advanced Analytics

Inovalon's cloud-based platform supports a highly differentiated use of data and analytics to optimize clinical outcomes and healthcare economics across the healthcare ecosystem SANTA CLARA, California, Nov. 5, 2019 /PRNewswire/ -- Based on its recent analysis of the North American data analytic...

2019-11-05 22:00 6388

Boehringer Ingelheim Applauded by Frost & Sullivan for Continuing to Lead the Bio-CDMO Market with Its Cutting-edge Innovation

LONDON, Nov. 5, 2019 /PRNewswire/ -- Based on its recent analysis of the global biologics contract development and manufacturing organization (CDMO) market, Frost & Sullivan recognises the biopharmaceutical contract development and manufacturing business ofGermany-headquartered Boehringer Ingelhe...

2019-11-05 21:00 387

Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)

80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months PLYMOUTH MEETING, Pennsylvania, Nov. 5, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today positive interim results from Inovio's Phase 2 study (NCT03491683) of newl...

2019-11-05 21:00 887

Canadian Brand, PureForm Pet Health Supplements, First to Launch Earth-Friendly Packaging

CHILLIWACK, British Columbia, Nov. 5, 2019 /PRNewswire/ -- PureForm Pet Health Supplements, based inChilliwack, BC, was the first in their industry to introduce biodegradable canisters and compostable shipping materials.

2019-11-05 21:00 342

Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

- Start-up companies ImagoWorks and Sibel recognized for novel health tech solutions that harness artificial intelligence, geometrical modeling and bio-integrated sensors aiming to improve the detection, prevention and and treatment of diseases SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Ja...

2019-11-05 13:00 1117

Cognate BioServices announces acquisition of Cobra Biologics

- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tennessee, Nov. 5, 2019 /PRNewswire/ -- Cognate BioServices...

2019-11-05 12:32 400

Farrer Park Hospital Introduces High Intensity Focused Ultrasound (HIFU) Treatment for Uterine Fibroid in Singapore

SINGAPORE, Nov. 5, 2019 /PRNewswire/ -- Farrer Park Hosiptal (FPH) introduces High Intensity Focused Ultrasound (HIFU) inSingapore. HIFU is a new technology for the treatment of uterine fibroids, adenomyoma, adenomyosis. It is a non-invasive surgery that uses focused ultrasound to generate hig...

2019-11-05 09:00 333

Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830

INCHEON, South Korea, Nov. 4, 2019 /PRNewswire/ -- Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treatment for moderate-to-severe atopic dermatitis....

2019-11-05 08:22 328

"Live bacteria" soil health and animal nutrition firm Terragen Holdings Ltd launches $20m IPO

* Australian agricultural microbial products company Terragen Holdings Ltd launches a$20 million initial public offer (IPO) of shares, comprising 80 million shares at25 cents per share * Terragen has developed and commercialised a range of biological products that use live microbes to address...

2019-11-05 06:10 473

Health Charities Benefit from Nationwide Fundraising Campaign

SYDNEY, Nov. 5, 2019 /PRNewswire/ -- AFT Pharmaceuticals is getting behind three charities in a bid to help them raise vital funding for vulnerable Aussies - and get people talking about health. The company's founder and CEO, Hartley Atkinson says the initiative is an opportunity to give back to...

2019-11-05 05:30 447

Mum Hails $10 Childs Farm Skincare Products "Life-changing" After They Clear Her Daughter's Severe Eczema

"As a parent it's so frustrating not to be able to help your child when they're in need. I just felt so useless." BRISBANE, Australia, Nov. 5, 2019 /PRNewswire/ -- Tamika Hayley from Brisbane , says using theChilds Farm skincare range

2019-11-05 03:00 439

Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation

SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- LY03004, Luye Pharma's innovative, independently developed Extended-Release Microspheres for Injection has taken another step closer to going on the U.S. market. The company has announced that it has received the Establishment Inspection Report from the U.S....

2019-11-05 00:39 376

Tencent and NEJM Yi Xue Qian Yan Host ME Summit to Promote Medical Science and Healthcare

BEIJING, Nov. 4, 2019 /PRNewswire/ -- Tencent Medipedia and NEJM Yi Xue Qian Yan, the Chinese version ofNew England Journal of Medicine, the world's leading medical journal and website under NEJM Group, jointly held the firstTencent Medical Enlightenment (ME) Summit inBeijing today. The Summit in...

2019-11-04 23:00 449

Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®

- Alliance to focus combined expertise and investment to maximise Jardiance® for people with type 2 diabetes, heart failure, and chronic kidney disease - Alliance to continue to include three product families – empagliflozin, linagliptin and insulin glargine INGELHEIM, Germany, and INDIANAPOLIS,...

2019-11-04 22:00 2881

China Biologic Products to Report Third Quarter 2019 Financial Results

BEIJING, Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 financial results o...

2019-11-04 21:30 6065

Seoul National University Bundang Hospital Achieves Global Healthcare Accreditation

PALM BEACH GARDENS, Florida, Nov. 4, 2019 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) (https://www.snubh.org/dh/en/) in Seoul, South Korea has been awarded a three-year term of accreditation by the Global Healthcare Accreditation (GHA) Program ( http://globalhealthcareaccre...

2019-11-04 21:00 447

Ossur and Alfred Mann Foundation Sign New Agreement to Extend Exploration of Mind-Controlled Prosthetics

REYKJAVIK, Iceland and SANTA CLARITA, CA, Nov. 4, 2019 /PRNewswire/ -- Jon Sigurdsson, President & CEO of Ossur and John Petrovich, CEO of the Alfred Mann Foundation (AMF) recently signed a milestone agreement that allows Ossur to further develop and license AMF's implanted myoelectric sensor (IM...

2019-11-04 15:37 2492

Picosun Expands Selection of Biocompatible ALD Materials for Medical Applications

ESPOO, Finland, Nov. 4, 2019 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions for global industries, expands its selection of biocompatible ALD materials to be used in medical applications. Picosun's TiO2 and Al2O3 processes ...

2019-11-04 13:00 362

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease

* Oligomannate, A New Oral Treatment For Mild To Moderate Alzheimer's Disease * The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- Shanghai Green Valley Pharmaceuticals (Green Valley) today announced thatChina's National Medical Products Administrat...

2019-11-04 10:30 521
12345678 ... 758